Gastroesophageal reflux disease: features in patients with metabolic syndrome
https://doi.org/10.21518/2079-701X-2014-13-49-53
Abstract
The article is a literature review of the major etiopathogenetic mechanisms and recent approaches to the treatment of gastroesophageal reflux disease in patients with metabolic syndrome. Recent data on the role of insulin resistance, impaired neurohumoral regulation of the upper gastrointestinal tract in patients with gastroesophageal reflux disease and metabolic syndrome is presented.
About the Authors
M. A. Livzan
Omsk State Medical Academy
Russian Federation
Russian Federation
E. A. Lyalyukova
Omsk State Medical Academy
Russian Federation
Russian Federation
I. V. Lapteva
Omsk State Medical Academy
Russian Federation
Russian Federation
References
1. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributableto alcohol use and alcohol-use disorders. Lancet, 2009, 373: 2223-2233.
2. Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al.Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut, 2010, 60: 977-984.
3. Leon DA, Collier T. Trends in mortality from liver cirrhosis in Europe in EASL meeting on alcoholic liver disease. Athens, 2010.
4. Parna K, Rahu K. Dramatic increase in alcoholic liver cirrhosis mortality in Estonia in 1992-2008. Alcohol Alcohol, 2010, 45: 548-551.
5. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction, 2000, 95: 1505-1523.
6. Klatsky AL. Alcohol and cardiovascular diseases. Expert Rev Cardiovasc Ther., 2009, 7: 499-506.
7. Shah VH. Alcoholic liver disease: the buzz may be gone, but the hangover remains. Hepatology 2009, 51: 14831484.
8. Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 2010, 29: 437-445.
9. Zakhari S, Li TK. Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology 2007, 46: 2032-2039.
10. Loft S, Olesen KL, Dossing M. Increased susceptibility to liver disease inrelation to alcohol consumption in women. Scand J Gastroenterol 1987, 22: 1251-1256.
11. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997, 25: 108-111.
12. Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, Kiyosawa K, et al. Peroxisome proliferator-activated receptor alpha protects against alcoholinduced liver damage. Hepatology 2004, 40: 972-980.
13. Hock B, Schwarz M, Domke I, Grunert VP, Wuertemberger M, Schiemann U et al. Validity of carbohydrate-deficient transferrin (% CDT), gammaglutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction 2005, 100: 1477-1486.
14. Naveau S, Gaude G, Asnacios A, Agostini H, Abella A, Barri-Ova N et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis inpatients with alcoholic liver disease. Hepatology, 2009,49: 97-105.
15. Philippe Mathurin; Antoine Hadengue; Ramon Bataller.EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease. European Association for the Study of the Liver Journal of Hepatology, 2012, 57: 399-420.
Review
For citations:
Livzan MA, Lyalyukova EA, Lapteva IV. Gastroesophageal reflux disease: features in patients with metabolic syndrome. Meditsinskiy sovet = Medical Council. 2014;(13):49-53. (In Russ.) https://doi.org/10.21518/2079-701X-2014-13-49-53
Views:
530
Email this article 